SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
Open accessAbstract
SLC7A11, the catalytic subunit of the cystine/glutamate antiporter, System x c − (SXC), is up-regulated in a subpopulation of patient gliomas, where it is responsible for excitotoxic glutamate release, accelerated tumor growth, and tumor-associated seizures.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Enhanced glutamatergic drive in tumor-associated epilepsy results from glutamate released from gliomas via the system Xc transporter (SXC) encoded by SLC7A11, which is upregulated in about 54% of glioma patients.
“The enhanced glutamatergic drive is the result of glutamate (Glu) being assiduously released from gliomas via system Xc transporter (SXC) encoded by the SLC7A11 gene that is upregulated in about 54% of glioma patients4.”
From Perineuronal nets decrease membrane capacitance of peritumoral fast spiking interneurons in a model of epilepsy (2018) · cites this paper as [4]
The cellular and molecular changes underlying tumor-associated epilepsy collectively point to a decrease in GABAergic and increase in glutamatergic transmission as the major contributors.
“The cellular and molecular changes underlying tumor-associated epilepsy collectively point to a decrease in GABAergic and increase in glutamatergic transmission as the major contributors3–6.”
From Perineuronal nets decrease membrane capacitance of peritumoral fast spiking interneurons in a model of epilepsy (2018) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,863 · see citing works
Hartigan, J. A., & Hartigan, P. M. (1985) · The Annals of Statistics · doi:10.1214/aos/1176346577 · Cited by 1,996 · see citing works
Ben-Ari, Y. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90299-4 · Cited by 1,753 · see citing works
Improved Method for Accurate and Efficient Quantification of MRS Data with Use of Prior Knowledge
Vanhamme, L., van den Boogaart, A., & Huffel, S. V. (1997) · Journal of Magnetic Resonance · doi:10.1006/jmre.1997.1244 · Cited by 1,631 · see citing works
Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,111 · see citing works
Excitotoxicity and stroke: Identifying novel targets for neuroprotection
Lai, T. W., Zhang, S., & Wang, Y. T. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.006 · Cited by 1,106 · see citing works
Java-based graphical user interface for the MRUI quantitation package
Naressi, A., Couturier, C., Devos, J. M., Janssen, M., Mangeat, C., de Beer, R., & Graveron‐Demilly, D. (2001) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/bf02668096 · Cited by 1,003 · see citing works
Glutamate release promotes growth of malignant gliomas
Takano, T., Lin, J. H.-C., Arcuino, G., Gao, Q., Yang, J., & Nedergaard, M. (2001) · Nature Medicine · doi:10.1038/nm0901-1010 · Cited by 602 · see citing works
Glutamate release by primary brain tumors induces epileptic activity
Buckingham, S. C., Campbell, S. L., Haas, B. R., Montana, V., Robel, S., Ogunrinu, T., & Sontheimer, H. (2011) · Nature Medicine · doi:10.1038/nm.2453 · Cited by 578 · see citing works
Self-citationExchange of cystine and glutamate across plasma membrane of human fibroblasts.
Bannai, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35926-4 · Cited by 543 · see citing works
Glioma cells release excitotoxic concentrations of glutamate.
Ye, Z., & Sontheimer, H. W. (1999) · PubMed · Cited by 442 · see citing works
Self-citationExcitotoxic mechanisms of epileptic brain damage.
Olney, J. W., Collins, R. C., & Sloviter, R. S. (1986) · PubMed · Cited by 393 · see citing works
Ye, Z., Rothstein, J. D., & Sontheimer, H. W. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10767.1999 · Cited by 353 · see citing works
Self-citationAutocrine Glutamate Signaling Promotes Glioma Cell Invasion
Lyons, S. A., Chung, W. J., Weaver, A. K., Ogunrinu, T., & Sontheimer, H. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2034 · Cited by 342 · see citing works
Self-citationGiannini, C., Sarkaria, J. N., Saito, A., Uhm, J. H., Galanis, E., Carlson, B. L., Schroeder, M. A., & James, C. D. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000821 · Cited by 326 · see citing works
Ishiuchi, S., Tsuzuki, K., Yoshida, Y., Yamada, N., Hagimura, N., Okado, H., Miwa, A., Kurihara, H., Nakazato, Y., Tamura, M., et al. (2002) · Nature Medicine · doi:10.1038/nm746 · Cited by 325 · see citing works
Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors
Chung, W. J., Lyons, S. A., Nelson, G. M., Hamza, H., Gladson, C. L., Gillespie, G. Y., & Sontheimer, H. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5258-04.2005 · Cited by 316 · see citing works
Self-citationGlutamate and the biology of gliomas
de Groot, J., & Sontheimer, H. W. (2010) · Glia · doi:10.1002/glia.21113 · Cited by 290 · see citing works
Self-citationSeizure Prognosis in Brain Tumors: New Insights and Evidence-Based Management
Vecht, C. J., Kerkhof, M., & Durán-Peña, A. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0060 · Cited by 249 · see citing works
Seizure characteristics and prognostic factors of gliomas
Kerkhof, M., & Vecht, C. J. (2013) · Epilepsia · doi:10.1111/epi.12437 · Cited by 246 · see citing works
Brenner, M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.01.055 · Cited by 222 · see citing works
Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR
Pandita, A., Aldape, K., Zadeh, G. M., Guha, A., & James, C. D. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10300 · Cited by 212 · see citing works
Efficacy of anti-epileptic drugs in patients with gliomas and seizures
van Breemen, M. S. M., Rijsman, R. M., TAPHOORN, M. J. B., Walchenbach, R., Zwinkels, H., & Vecht, C. J. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5156-9 · Cited by 202 · see citing works
Ca2+-Permeable AMPA Receptors Regulate Growth of Human Glioblastoma via Akt Activation
Ishiuchi, S., Yoshida, Y., Sugawara, K., Aihara, M., Ohtani, T., Watanabe, T., Saito, N., Tsuzuki, K., Okado, H., Miwa, A., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2180-07.2007 · Cited by 194 · see citing works
Savaskan, N. E., Heckel, A., Hahnen, E., Engelhorn, T., Doerfler, A., Ganslandt, O., Nimsky, C., Buchfelder, M., & Eyüpoglu, I. Y. (2008) · Nature Medicine · doi:10.1038/nm1772 · Cited by 192 · see citing works
Marcus, H. J., Carpenter, K. L. H., Price, S. J., & Hutchinson, P. J. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9990-5 · Cited by 184 · see citing works
Chaichana, K. L., Park, P., Olivi, A., & Quiñones‐Hinojosa, A. (2009) · Journal of neurosurgery · doi:10.3171/2009.2.jns081132 · Cited by 183 · see citing works
Williams, S. R., Christensen, S. R., Stuart, G. J., & Häusser, M. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013136 · Cited by 181 · see citing works
Jensen, A., & Chiu, S. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-04-01165.1990 · Cited by 175 · see citing works
Glutamate is associated with a higher risk of seizures in patients with gliomas
Yuen, T., Morokoff, A. P., Bjorksten, A. R., D’Abaco, G. M., Paradiso, L., Finch, S. J., Wong, D., Reid, C. A., Powell, K. L., Drummond, K. J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318266fa89 · Cited by 173 · see citing works
Piao, Y., Lu, L., & de Groot, J. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-094 · Cited by 124 · see citing works
Selective Vulnerability of the Brain: New Insights into the Pathophysiology of Stroke
Collins, R. C., Dobkin, B. H., & Choi, D. W. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-12-992 · Cited by 123 · see citing works
Assessments of Function and Biochemistry of the Anterior Cingulate Cortex in Schizophrenia
Reid, M. A., Stoeckel, L. E., White, D. M., Avsar, K. B., Bolding, M., Akella, N. S., Knowlton, R. C., den Hollander, J. A., & Lahti, A. C. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.013 · Cited by 122 · see citing works
Self-citationCharacterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging
Rijpkema, M., Schuuring, J., van der Meulen, Y. M., van der Graaf, M., Bernsen, H. J. J. A., Boerman, R. H., van der Kogel, A., & Heerschap, A. (2003) · NMR in Biomedicine · doi:10.1002/nbm.807 · Cited by 117 · see citing works
Ludwin, S. K. (1985) · PubMed · Cited by 111 · see citing works
Regulation of astrocyte glutamine synthetase in epilepsy
Eid, T., Tu, N., Lee, T.-S. W., & Lai, J. C. K. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.008 · Cited by 109 · see citing works
Dun, Y., Mysona, B. A., Ells, T. K. V., Amarnath, L. P., Ola, M. S., Ganapathy, V., & Smith, S. B. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0116-x · Cited by 102 · see citing works
Increased xCT Expression Correlates With Tumor Invasion and Outcome in Patients With Glioblastomas
Takeuchi, S., Wada, K., Toyooka, T., Shinomiya, N., Shimazaki, H., Nakanishi, K., Nagatani, K., Otani, N., Osada, H., Uozumi, Y., et al. (2012) · Neurosurgery · doi:10.1227/neu.0b013e318276b2de · Cited by 102 · see citing works
Bursting induces persistent all-or-none EPSPs by an NMDA-dependent process in piriform cortex
Hoffman, W. H., & Haberly, L. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-01-00206.1989 · Cited by 101 · see citing works
Hypoxia Increases the Dependence of Glioma Cells on Glutathione
Ogunrinu, T., & Sontheimer, H. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.161190 · Cited by 96 · see citing works
Self-citationBradykinin-Induced Chemotaxis of Human Gliomas Requires the Activation of KCa3.1 and ClC-3
Cuddapah, V. A., Turner, K. L., Seifert, S., & Sontheimer, H. W. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3980-12.2013 · Cited by 90 · see citing works
Self-citationBursting-induced epileptiform EPSPs in slices of piriform cortex are generated by deep cells
Hoffman, W. H., & Haberly, L. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-07-02021.1991 · Cited by 89 · see citing works
Role of glutathione in cancer pathophysiology and therapeutic interventions.
Singh, S., Khan, A. R., & GUPTA, A. K. (2012) · PubMed · Cited by 88 · see citing works
Seizures Following Intracranial Surgery: Incidence in the First Post-Operative Week
Matthew, E. M., Sherwin, A. L., Welner, S. A., Odusote, K. A., & Stratford, J. G. (1980) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100022757 · Cited by 87 · see citing works
NHERF-1: Modulator of Glioblastoma Cell Migration and Invasion
Kislin, K. L., McDonough, W. S., Eschbacher, J. M., Armstrong, B. A., & Berens, M. E. (2009) · Neoplasia · doi:10.1593/neo.81572 · Cited by 79 · see citing works
Self-citationPharmacotherapy of Epileptic Seizures in Glioma Patients: Who, When, Why and How Long?
Wick, W., Menn, O., Meisner, C., Steinbach, J. P., Hermisson, M., Tatagiba, M. S., & Weller, M. (2005) · Oncology Research and Treatment · doi:10.1159/000086375 · Cited by 79 · see citing works
Iijima, T., Mishima, T., Akagawa, K., & Iwao, Y. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.041 · Cited by 78 · see citing works
Martinian, L., Boer, K., Middeldorp, J., Hol, E. M., Sisodiya, S. M., Squier, W., Aronica, E., & Thom, M. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00996.x · Cited by 73 · see citing works
The mTOR pathway is activated in glial cells in mesial temporal sclerosis
Sosunov, A. A., Wu, X., McGovern, R. A., Coughlin, D. G., Mikell, C. B., Goodman, R. R., & McKhann, G. M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03478.x · Cited by 68 · see citing works
Seib, T., Patel, S. A., & Bridges, R. J. (2011) · Glia · doi:10.1002/glia.21176 · Cited by 63 · see citing works
BERKENBOSCH, F., Refolo, L. M., Friedrich, V. L., Casper, D., Blum, M., & Robakis, N. K. R. K. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490250321 · Cited by 61 · see citing works
Role of glutamate transporters in redox homeostasis of the brain
Robert, S. M., Ogunrinu, T., Holt, K. T., & Sontheimer, H. W. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.01.001 · Cited by 53 · see citing works
Self-citationLu, C., Li, J., Sun, W., Feng, L., Li, L., Liu, A., Li, J., Mao, W., Wei, H., Gao, L., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.036 · Cited by 48 · see citing works
Inhibition of xc- transporter-mediated cystine uptake by sulfasalazine analogs
Shukla, K. H., Thomas, A. G., Ferraris, D. V., Hin, N., Sattler, R., Alt, J., Rojas, C. J., Slusher, B. S., & Tsukamoto, T. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.081 · Cited by 45 · see citing works
Bonová, P., Bürda, J., Danielisová, V., Némethová, M., & Gottlieb, M. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.019 · Cited by 30 · see citing works
Kinase activation of ClC-3 accelerates cytoplasmic condensation during mitotic cell rounding
Cuddapah, V. A., Habela, C. W., Watkins, S., Moore, L. S., Barclay, T.-T. C., & Sontheimer, H. W. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00248.2011 · Cited by 29 · see citing works
Self-citationLeuraud, P., Taillandier, L., Aguirre‐Cruz, L., Médioni, J., Crinière, E., Marie, Y., Dutrillaux, A., Kujas, M., Duprez, A., Delattre, J.-Y., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601466 · Cited by 18 · see citing works
Newell, J. L., Keyari, C. M., McDaniel, S. W., Diaz, P., Natale, N. R., Patel, S. A., & Bridges, R. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.11.012 · Cited by 15 · see citing works
A Review of the Use of Antiepileptic Drugs in High-Grade Central Nervous System Tumors
Wallace, E. M., O’Reilly, M. A., & Twomey, M. (2012) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909111434367 · Cited by 6 · see citing works
Stockhammer, F., von Deimling, A., & van Landeghem, F. K. H. (2009) · Histopathology · doi:10.1111/j.1365-2559.2008.03153.x · Cited by 4 · see citing works
Flagged first, then by citations
1 of the 61 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [57]Giannini C Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme Neuro-oncology 7 164 176 2005 15831234 PMC1871885
Cited by
Sorted by citations
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,698 · see citing works
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,942 · see citing works
Targeting Ferroptosis as a Vulnerability in Cancer
Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252 · see citing works
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.013 · Cited by 763 · see citing works
Neuron–glia interactions in the pathophysiology of epilepsy
Patel, D. C., Tewari, B. P., Chaunsali, L., & Sontheimer, H. W. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0126-4 · Cited by 461 · see citing works
Self-citationBreakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis
Anandhan, A., Dodson, M. B., Schmidlin, C. J., Liu, P., & Zhang, D. D. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.03.011 · Cited by 439 · see citing works
ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
Chen, D., Fan, Z., Rauh, M., Buchfelder, M., Eyupoglu, I. Y., & Savaskan, N. (2017) · Oncogene · doi:10.1038/onc.2017.146 · Cited by 421 · see citing works
Hu, K., Li, K., Lv, J., Feng, J., Chen, J., Wu, H., Cheng, F., Jiang, W., Wang, J., Pei, H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124049 · Cited by 409 · see citing works
Lin, H., Liu, C., Hu, A.-K., Zhang, D., Yang, H., & Mao, Y. Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 424 · see citing works
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
Roh, J., Kim, E. H., Jang, H. J., Park, J. Y., & Shin, D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.035 · Cited by 375 · see citing works
Cysteine Metabolism in Neuronal Redox Homeostasis
Paul, B. D., Sbodio, J. I., & Snyder, S. H. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.007 · Cited by 356 · see citing works
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
Ji, X., Qian, J., Rahman, S. M. J., Siska, P. J., Zou, Y., Harris, B. K., Hoeksema, M. D., Trenary, I. A., Chen, H., Eisenberg, R., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0307-z · Cited by 351 · see citing works
Influence of glutamate and GABA transport on brain excitatory/inhibitory balance
Sears, S. M. S., & Hewett, S. J. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370221989263 · Cited by 348 · see citing works
Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes
Maschalidi, S., Mehrotra, P., Keçeli, B. N., Cleene, H. K. L. D., Lecomte, K., der Cruyssen, R. V., Janssen, P., Pinney, J. J., Loo, G., Elewaut, D. S., et al. (2022) · Nature · doi:10.1038/s41586-022-04754-6 · Cited by 333 · see citing works
Glioblastoma at the crossroads: current understanding and future therapeutic horizons
Singh, S., Dey, D., Barik, D., Mohapatra, I., Kim, S., Sharma, M., Prasad, S., Wang, P., Singh, A. R., & Singh, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02299-4 · Cited by 332 · see citing works
Challenges in glioblastoma research: focus on the tumor microenvironment
Bikfalvi, A., da Costa, C. A., Avril, T., Barnier, J., Bauchet, L., Brisson, L., Cartron, P., Castel, H., Chevet, É., Chneiweiss, H., et al. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.09.005 · Cited by 309 · see citing works
Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy
Wang, W., & Zou, W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.006 · Cited by 304 · see citing works
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Jyotsana, N., Ta, K. T. L., & DelGiorno, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858462 · Cited by 275 · see citing works
Tumor Neurobiology and the War of Nerves in Cancer
Faulkner, S., Jobling, P., March, B., Jiang, C. C., & Hondermarck, H. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1398 · Cited by 271 · see citing works
SLC7A11/xCT in cancer: biological functions and therapeutic implications.
Lin, W., Wang, C., Liu, G., Bi, C., Wang, X., Zhou, Q., & Jin, H. (2020) · PubMed Central · Cited by 266 · see citing works
Molecular basis for redox control by the human cystine/glutamate antiporter system xc−
Parker, J. L., Deme, J. C., Kolokouris, D., Kuteyi, G., Biggin, P. C., Lea, S. M., & Newstead, S. L. (2021) · Nature Communications · doi:10.1038/s41467-021-27414-1 · Cited by 258 · see citing works
System Xc−: a key regulatory target of ferroptosis in cancer
Liu, M.-R., Zhu, W.-T., & Pei, D. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01070-0 · Cited by 257 · see citing works
Verdugo, E., Puerto, I., & Medina, M. Á. (2022) · 癌症:英文版 · doi:10.1002/cac2.12361 · Cited by 250 · see citing works
Human astrocytes in the diseased brain
Dossi, E., Vasile, F., & Rouach, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.02.001 · Cited by 250 · see citing works
Vazquez, A., Kamphorst, J. J., Markert, E. K., Schug, Z. T., Tardito, S., & Gottlieb, E. (2016) · Journal of Cell Science · doi:10.1242/jcs.181016 · Cited by 225 · see citing works
Recent progress of drug nanoformulations targeting to brain
Khan, A. R., Yang, X., Fu, M., & Zhai, G. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.004 · Cited by 212 · see citing works
Gu, Y., de Albuquerque, C. P., Braas, D., Zhang, W., Villa, G. R., Bi, J., Ikegami, S., Masui, K., Gini, B., Yang, H., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.030 · Cited by 210 · see citing works
Tewari, B. P., Chaunsali, L., Campbell, S. L., Patel, D. C., Goode, A. E., & Sontheimer, H. (2018) · Nature Communications · doi:10.1038/s41467-018-07113-0 · Cited by 208 · see citing works
Self-citationSeizures and gliomas — towards a single therapeutic approach
Huberfeld, G., & Vecht, C. J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.26 · Cited by 204 · see citing works
Glia as drivers of abnormal neuronal activity
Robel, S., & Sontheimer, H. W. (2015) · Nature Neuroscience · doi:10.1038/nn.4184 · Cited by 199 · see citing works
Self-citationRemote neuronal activity drives glioma progression through SEMA4F
Huang-Hobbs, E., Cheng, Y.-T., Ko, Y., Luna-Figueroa, E., Lozzi, B., Taylor, K. R., McDonald, M. F., He, P., Chen, H., Yang, Y., et al. (2023) · Nature · doi:10.1038/s41586-023-06267-2 · Cited by 196 · see citing works
Upadhyayula, P. S., Higgins, D. M. O., Mela, A., Banu, M. A., Dovas, A., Zandkarimi, F., Patel, P. R., Mahajan, A., Humala, N., Nguyen, T. T. T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36630-w · Cited by 191 · see citing works
Esteras, N., Dinkova‐Kostova, A. T., & Abramov, A. Y. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0295 · Cited by 161 · see citing works
Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy: Table 1.
Armstrong, T. S., Grant, R., Gilbert, M. R., Lee, J. W., & Norden, A. D. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov269 · Cited by 157 · see citing works
Role and mechanism of ferroptosis in neurological diseases
Ou, M., Jiang, Y., Ji, Y., Zhou, Q., Du, Z., Zhu, H., & Zhou, Z. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101502 · Cited by 148 · see citing works
Polewski, M. D., Reveron‐Thornton, R. F., Cherryholmes, G. A., Marinov, G. K., Cassady, K. M., & Aboody, K. S. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0028 · Cited by 135 · see citing works
Sehm, T., Fan, Z., Ghoochani, A., Rauh, M., Engelhorn, T., Minakaki, G., Dörfler, A., Klucken, J., Buchfelder, M., Eyüpoglu, I. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8651 · Cited by 134 · see citing works
Pál, B. Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2837-5 · Cited by 135 · see citing works
Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis
Sehm, T., Rauh, M., Wiendieck, K., Buchfelder, M., Eyüpoglu, I. Y., & Savaskan, N. E. (2016) · Oncotarget · doi:10.18632/oncotarget.11858 · Cited by 129 · see citing works
Hatem, E., Banna, N. E., & Huang, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7134 · Cited by 126 · see citing works
Shandra, O. O., Winemiller, A. R., Heithoff, B. P., Muñoz‐Ballester, C., George, K. K., Benko, M. J., Zuidhoek, I. A., Besser, M. N., Curley, D. E., Edwards, G. F., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1067-18.2018 · Cited by 124 · see citing works
Self-citationLiu, N., Zhang, J., Yin, M., Liu, H., Zhang, X., Li, J., Yan, B., Guo, Y., Zhou, J., Tao, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.013 · Cited by 126 · see citing works
Han, C., Ge, M., Xing, P., Xia, T., Zhang, C., Ma, K., Ma, Y., Li, S., Li, W., Liu, X., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06503-1 · Cited by 116 · see citing works
Tsuchihashi, K., Okazaki, S., Ohmura, M., Ishikawa, M., Sampetrean, O., Onishi, N., Wakimoto, H., Yoshikawa, M., Seishima, R., Iwasaki, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2121 · Cited by 113 · see citing works
Role of the Microenvironment in Glioma Pathogenesis
Jayaram, M. A., & Phillips, J. J. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-110348 · Cited by 112 · see citing works
Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model
Hatcher, A., Yu, K., Meyer, J. F., Aiba, I., Deneen, B., & Noebels, J. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133316 · Cited by 107 · see citing works
Targeting Glutamine Addiction in Gliomas
Obara‐Michlewska, M., & Szeliga, M. (2020) · Cancers · doi:10.3390/cancers12020310 · Cited by 105 · see citing works
Hanssen, K. M., Haber, M., & Fletcher, J. I. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100795 · Cited by 102 · see citing works
Montgomery, M. K., Kim, S. H., Dovas, A., Zhao, H., Goldberg, A., Xu, W., Yagielski, A. J., Cambareri, M. K., Patel, K., Mela, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.064 · Cited by 104 · see citing works
Interactions between Tumor Cells, Neurons, and Microglia in the Glioma Microenvironment
Radin, D. P., & Tsirka, S. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228476 · Cited by 99 · see citing works
Joly, J. H., Delfarah, A., Phung, P. S., Parrish, S., & Graham, N. A. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49891-7 · Cited by 97 · see citing works
Ferroptosis in life: To be or not to be
Xu, L., Liu, Y., Chen, X., Zhong, H., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114241 · Cited by 98 · see citing works
AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro
Lange, F., Weßlau, K., Porath, K., Hörnschemeyer, M. F., Bergner, C., Krause, B. J., Mullins, C. S., Linnebacher, M., Köhling, R., & Kirschstein, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211644 · Cited by 94 · see citing works
Regulated cell death in cancer: from pathogenesis to treatment
Gong, L., Huang, D., Shi, Y., Liang, Z., & Bu, H. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002239 · Cited by 94 · see citing works
Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy
Lange, F., Hörnschemeyer, M. F., & Kirschstein, T. (2021) · Cells · doi:10.3390/cells10051226 · Cited by 94 · see citing works
Ferroptosis: Cancer Stem Cells Rely on Iron until “to Die for” It
Cosialls, E., Elhage, R., Santos, L. D., Gong, C., Mehrpour, M., & Hamaï, A. (2021) · Cells · doi:10.3390/cells10112981 · Cited by 90 · see citing works
Ottestad‐Hansen, S., Hu, Q. X., Follin‐Arbelet, V. V., Bentea, E., Sato, H., Massie, A., Zhou, Y., & Danbolt, N. C. (2018) · Glia · doi:10.1002/glia.23294 · Cited by 88 · see citing works
Joly, J. H., Delfarah, A., Phung, P. S., Parrish, S., & Graham, N. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011471 · Cited by 88 · see citing works
Glutamate weighted imaging contrast in gliomas with 7 Tesla magnetic resonance imaging
Neal, A. J., Moffat, B. A., Stein, J. M., Nanga, R. P. R., Desmond, P. M., Shinohara, R. T., Hariharan, H., Glarin, R. K., Drummond, K. J., Morokoff, A. P., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101694 · Cited by 86 · see citing works
Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation
Curry, R. N., Aiba, I., Meyer, J. F., Lozzi, B., Ko, Y., McDonald, M. F., Rosenbaum, A., Cervantes, A., Huang-Hobbs, E., Cocito, C., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.013 · Cited by 84 · see citing works
Wan, S., Zhang, G., Liu, R., Abbas, M. N., & Cui, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01108-1 · Cited by 83 · see citing works
Zille, M., Kumar, A., Kundu, N., Bourassa, M. W., Wong, V. S. C., Willis, D. E., Karuppagounder, S. S., & Ratan, R. R. (2019) · eNeuro · doi:10.1523/eneuro.0263-18.2019 · Cited by 84 · see citing works
Portela, M., Venkataramani, V., Fahey-Lozano, N., Seco, E., Losada‐Pérez, M., Winkler, F., & Casas‐Tintó, S. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000545 · Cited by 76 · see citing works
Tang, B., Wang, Y., Xu, W., Zhu, J., Weng, Q., Chen, W., Fang, S., Yang, Y., Qiu, R., Chen, M., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216021 · Cited by 74 · see citing works
xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction
Cobler, L., Zhang, H., Suri, P., Park, C., & Timmerman, L. (2018) · Oncotarget · doi:10.18632/oncotarget.25794 · Cited by 72 · see citing works
Su, X., Xie, Y., Zhang, J., Li, M., Zhang, Q., Jin, G., & Liu, F. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05304-8 · Cited by 70 · see citing works
Astrocytes as a target for therapeutic strategies in epilepsy: current insights
Çarçak, N., Onat, F., & Sitnikova, E. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1183775 · Cited by 69 · see citing works
Sørensen, M. F., Heimisdóttir, S. B., Sørensen, M. D., Mellegaard, C. S., Wohlleben, H., Kristensen, B. W., & Beier, C. P. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2785-9 · Cited by 68 · see citing works
Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications
Yin, L., Liu, P., Jin, Y., Ning, Z., Yang, Y., & Gao, H. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114861 · Cited by 66 · see citing works
Glioblastoma quo vadis : Will migration and invasiveness reemerge as therapeutic targets?
Lefranc, F., Rhun, É. L., Robert Kiss, A., & Weller, M. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.06.017 · Cited by 66 · see citing works
Binder, D. K., & Steinhäuser, C. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03236-x · Cited by 65 · see citing works
Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies
Woo, Y., Lee, H.-J., Jung, Y. M., & Jung, Y. (2020) · Cells · doi:10.3390/cells9122709 · Cited by 65 · see citing works
Wang, M., Zhao, Y., Yu, Z., Zhang, R.-D., Li, S., Zhang, P., Shan, T.-K., Liu, X., Wang, Z.-M., Zhao, P., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01566-4 · Cited by 63 · see citing works
Guo, X., Qiu, W., Li, B., Qi, Y., Wang, S., Zhao, R., Cheng, B., Han, X., Du, H., Pan, Z., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0430 · Cited by 63 · see citing works
Research progress on SLC7A11 in the regulation of cystine/cysteine metabolism in tumors (Review)
Tang, X., Chen, W., Liu, H., Liu, N., Chen, D., Tian, D., & Wang, J. (2021) · Oncology Letters · doi:10.3892/ol.2021.13165 · Cited by 60 · see citing works
Seizures in glioma patients: An overview of incidence, etiology, and therapies
Samudra, N. P., Zacharias, T., Plitt, A. R., Lega, B. C., & Pan, E. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.07.026 · Cited by 59 · see citing works
Guo, X., Qiu, W., Wang, C., Qi, Y., Li, B., Wang, S., Zhao, R., Cheng, B., Han, X., Du, H., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0609 · Cited by 59 · see citing works
Mittra, E., Koglin, N., Mosci, C., Kumar, M., Höhne, A., Keu, K. V., Iagaru, A. H., Mueller, A., Berndt, M., Bullich, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148628 · Cited by 56 · see citing works
Zhao, X., Zhou, M., Yang, Y., & Luo, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.2011633 · Cited by 53 · see citing works
Dahlmanns, M., Dahlmanns, J. K., Savaskan, N. E., Steiner, H. H., & Yakubov, E. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2803057 · Cited by 52 · see citing works
Binder, D. K., & Steinhäuser, C. (2016) · Elsevier eBooks · doi:10.1016/c2014-0-03100-0 · Cited by 52 · see citing works
A map of the altered glioma metabolism
Deshmukh, R. S., Allega, M. F., & Tardito, S. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.011 · Cited by 52 · see citing works
Jiang, Y., Cui, J., Cui, M., & Jing, R. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154646 · Cited by 48 · see citing works
Ma, Z., Zhang, H., Lian, M., Yue, C., Dong, G., Jin, Y., Li, R., Wan, H., Wang, R., Wang, Y., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5976 · Cited by 48 · see citing works
Potassium and glutamate transport is impaired in scar-forming tumor-associated astrocytes
Campbell, S. C., Muñoz‐Ballester, C., Chaunsali, L., Mills, W. A., Yang, J. H., Sontheimer, H. W., & Robel, S. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104628 · Cited by 49 · see citing works
Self-citationZhang, N., Huang, J., Xu, M., & Wang, Y. (2022) · Journal of Cancer · doi:10.7150/jca.65017 · Cited by 47 · see citing works
Does the choice of antiepileptic drug affect survival in glioblastoma patients?
Knudsen-Baas, K. M., Engeland, A., Gilhus, N. E., Storstein, A. M., & Owe, J. F. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2191-0 · Cited by 47 · see citing works
Shen, L., Qian, C., Cao, H., Wang, Z., Luo, T., & Liang, C. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1535-y · Cited by 47 · see citing works
Multi‐omics technologies and molecular biomarkers in brain tumor‐related epilepsy
Du, Y., Li, R., Fu, D., Zhang, B., Cui, A., Shao, Y., Lai, Z., Chen, R., Chen, B., Wang, Z., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14717 · Cited by 45 · see citing works
Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring
Scalise, M., Console, L., Rovella, F., Galluccio, M., Pochini, L., & Indiveri, C. (2020) · Cells · doi:10.3390/cells9092028 · Cited by 45 · see citing works
Dysregulation of Ambient Glutamate and Glutamate Receptors in Epilepsy: An Astrocytic Perspective
Alcoreza, O. B., Patel, D. C., Tewari, B. P., & Sontheimer, H. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.652159 · Cited by 44 · see citing works
Self-citationComparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed
Liefferinge, J. V., Bentea, E., Demuyser, T., Albertini, G., Follin-Arbelet, V. V., Holmseth, S., Merckx, E., Sato, H., Aerts, J. L., Smolders, I. J., et al. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23889 · Cited by 44 · see citing works
Jin, C., Zhang, P., Zhang, M., Zhang, X., Lv, L., Liu, H., Liu, Y., & Zhou, Y. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3009 · Cited by 44 · see citing works
Liu, L., Cheng, M., Zhang, T., Chen, Y., Wu, Y., & Wang, Q. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09652-7 · Cited by 43 · see citing works
mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance
Woo, Y., Lee, H.-J., Jung, Y. M., & Jung, Y. (2019) · Journal of Oncology · doi:10.1155/2019/5956867 · Cited by 42 · see citing works
Li, Y., Yan, B., Wu, Y., Peng, Q., Wei, Y., Chen, Y., Zhang, Y., Ma, N., Xu, Y., & Ma, P. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114848 · Cited by 42 · see citing works
Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
Zhuo, S., He, G., Chen, T., Li, X., Liang, Y., Wu, W., Weng, L., Feng, J., Gao, Z., & Yang, K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.974156 · Cited by 43 · see citing works
Zhang, Y., Duan, W., Chen, L., Chen, J., Xu, W., Fan, Q., Li, S., Liu, Y., Wang, S., He, Q., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.10.016 · Cited by 40 · see citing works
Stone, T. J., Rowell, R., Jayasekera, B. A. P., Cunningham, M. O., & Jacques, T. S. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12459 · Cited by 40 · see citing works
Seizures as presenting symptom in patients with glioblastoma
Dührsen, L., Sauvigny, T., Ricklefs, F. L., Mende, K. C., Schaper, M., Matschke, J., Goebell, E., Westphal, M., & Martens, T. (2018) · Epilepsia · doi:10.1111/epi.14615 · Cited by 41 · see citing works
- Authors
- Robert, S. M., Buckingham, S. C., Campbell, S. L., Robel, S., Holt, K. T., Ogunrinu-Babarinde, T., Warren, P. P., White, D. M., Reid, M. A., Eschbacher, J. M., Berens, M. E., Lahti, A. C., Nabors, L. B., & Sontheimer, H.
- Affiliations
- University of Alabama at Birmingham (US)
- Department of Neurobiology, Center for Glial Biology in Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Translational Genomics Research Institute (US)
- Division of Neuro-oncology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Corresponding author
- Sontheimer, Harald
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2015-05-27
- Volume
- 7
- Issue
- 289
- Pages
- 289ra86-289ra86
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC4503260
- OpenAlex
- W2099513242
- Cited by
- 301
- References
- 61
- Citations by year
- 2026: 29 · 2025: 31 · 2024: 32 · 2023: 34 · 2022: 26 · 2021: 32 · 2020: 22 · 2019: 26 · 2018: 22 · 2017: 19 · 2016: 23 · 2015: 5
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (5R01NS052634, 2RO1NS036692, 5RO1NS031234, 1F31NS074597, 1R01NS082851, 5TL1RR025775-04, 2T32NS048039, T32GM008361, T32GM008362)
- Ben & Catherine Ivy Foundation
- Topics
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- SLC7A11, system xc-, high-grade glioma, seizures, glutamate release, glutathione synthesis, tumor growth, overall survival, sulfasalazine, magnetic resonance spectroscopy, prognostic factors
- MeSH terms
- Edema, Glioma, Glutamates, Humans, Neurons, Neurotoxins, Seizures, Survival Analysis, Genomics, Amino Acid Transport System y+
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review